A clinical trial has opened in Poland that will test whether regorafenib can be used to treat bone cancers. We interviewed trial lead Professor Raciborsk.

A recent study looked at immune cells in osteosarcoma . The aim was to provide insight into the immune landscape and potentially shed some light on how it could be targeted by drugs.

Dr. Matteo Trucco has launched a sarcoma clinical trial. It aims to see if disulfiram could be repurposed to be used in sarcoma treatment.  

In the last 30 years there has been very little change to osteosarcoma (OS) treatment. We are dedicated to changing this. Through the Myrovlytis Trust, we fund research into OS, with a focus on finding new treatments. We are pleased to announce we have awarded funding...

Welcome to the ONTEX social media toolkit. We are delighted to have launched our new improved Osteosarcoma Now Trial EXplorer (ONTEX). Each osteosarcoma clinical trial has been summarised to give a clear picture of its aims, what it involves and who can take part. Its...

We are delighted to launch our new improved Osteosarcoma Now Trial EXplorer (ONTEX). ONTEX is an international database that aims to make clinical trial information available and accessible to all. Each osteosarcoma clinical trial has been summarised to give a clear...

Our work in osteosarcoma started in 2021, with many months dedicated to talking with experts, patients and other charities. In this blog we reflect on what we achieved in 2022.

Hello Everyone. We are closed from Friday 23rd December until Tuesday 3rd January. During that time all the content on the website will be available but we will be taking a break from the weekly blogs. On our return, we will respond to any emails. From all of us at...

Sign up for the Osteosarcoma Now Newsletter. Each issue will discuss the current research and signpost to events across the world.

We attended the 2022 CTOS annual meeting. The meeting brought together clinicians, researchers and patient advocates dedicated to improving outcomes in sarcoma.